Cite

HARVARD Citation

    Ma, Y. et al. (2023). A miRNA-based gene therapy nanodrug synergistically enhances pro-inflammatory antitumor immunity against melanoma. Acta biomaterialia. pp. 538-553. [Online]. 
  
Back to record